References
Borgaonkar MR. Hemochromatosis: More common than you think. Can Fam Physician. 2003 Jan;49:36–43.
Britton RS, Leicester KL, et al. Iron toxicity and chelation therapy. Int Journal Hematology. 2002 Oct;76(3):219–28.
Chawla RK, Bonkovsky HL, et al. Biochemistry and pharmacology of
S-adenosyl-L-methionine and rationale for its use in liver disease.
Drugs. 1990;40 Suppl 3:98-110.
Crowe S. Amlodipine decreases iron uptake and oxygen free radical
production in the heart of chronically iron overloaded mice. Biology
Res Nursing. 2002 Apr;3(4):189–97.
Hallberg L. Does calcium interfere with iron absorption? Am J Clin Nutr. 1998 Jul;68(1):3–4.
Kaltwasser JP, Werner E, et al. Clinical trial on the effect of
regular tea drinking on iron accumulation in genetic haemochromatosis.
Gut. 1998;43(5):699–704.
Kasper DL, Braunwald E, et al. Harrison’s Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2005: 2298–303.
Kidd P. Glutathione: Systemic protectant against oxidative and free radical damage. Alt Med Review. 2005.
Murray M. Iron. In: Murphy MT, ed. Encyclopedia of Nutritional Supplements. Rocklin, Calif: Prima Publishing; 1996:208.
Young IS, Trouton TG, et al. Antioxidant status and lipid
peroxidation in hereditary haemochromatosis. Free Radic Biol Med. 1994
Mar;16(3):393–7.
Print
PDF
Email
View Health Concern
